Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Thomas G. von Lueder"'
Autor:
Tea Sætereng Fyksen, Paul Vanberg, Knut Gjesdal, Thomas G. von Lueder, Reidar Bjørnerheim, Kjetil Steine, Dan Atar, Sigrun Halvorsen
Publikováno v:
Scandinavian journal of medicinescience in sports. 32(8)
Introduction Abuse of anabolic-androgenic steroids (AAS) has been linked to a variety of different cardiovascular (CV) side effects, but still the clinical effects of AAS abuse on CV risk are not clear. The aim of this study was to assess the CV phen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37692b7af491228526b1ee4e3211c36
https://pubmed.ncbi.nlm.nih.gov/35460300
https://pubmed.ncbi.nlm.nih.gov/35460300
Autor:
Otto A. Smiseth, Stevo Julius, Richard B. Devereux, Ingrid Hopper, Faiez Zannad, Bertram Pitt, Thomas G. von Lueder, Christopher M. Reid, Nisha Mistry, Kristian Wachtell, Sverre E. Kjeldsen, Arne Westheim
Publikováno v:
Hypertension. 75:23-32
Current cardiovascular pharmacotherapy targets maladaptive overactivation of the renin-angiotensin-aldosterone system (RAAS), which occurs throughout the continuum of cardiovascular disease spanning from hypertension to heart failure with reduced eje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4315befea84c75214e39fd61cd1cc507
https://doi.org/10.1161/hypertensionaha.119.14057
https://doi.org/10.1161/hypertensionaha.119.14057
Autor:
Stefan Agewall, Jesper K. Jensen, Thomas G. von Lueder, Ingrid Hopper, Dipak Kotecha, Dan Atar, Moo Hyun Kim, Victor L. Serebruany, Robert J. Mentz
Publikováno v:
von Lueder, T G, Atar, D, Agewall, S, Jensen, J K, Hopper, I, Kotecha, D, Mentz, R J, Kim, M H & Serebruany, V L 2019, ' All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System ', American Journal of Therapeutics, vol. 26, no. 6, pp. e671-e678 . https://doi.org/10.1097/MJT.0000000000000883
BACKGROUND: Many patients with heart failure (HF) are treated with warfarin or non-vitamin K oral anticoagulants (NOACs). Randomized outcome-driven comparisons of different anticoagulant strategies in HF are lacking. Data from international, governme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b600a199dfd787497131ceec46f9df99
https://doi.org/10.1097/mjt.0000000000000883
https://doi.org/10.1097/mjt.0000000000000883
Autor:
Erik Høiskar, Cecilie Nyvold, Odd Johansen, Kristin Astrid Berland Øystese, Ingrid Norheim, Thomas G. von Lueder, Geir Øystein Andersen, Marianne Voll
Publikováno v:
European Heart Journal: Case Reports
Background Thyroid storm is a life-threatening condition. Refractory cardiogenic shock and cardiac arrest are rare complications of thyroid storm and the treatment options are limited. Case summary A 35-year- old woman treated for Grave’s disease w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ef295d08830bbcee0ba3a0ed37a798
https://doi.org/10.1093/ehjcr/ytab017
https://doi.org/10.1093/ehjcr/ytab017
Autor:
Giuseppe Mancia, Thomas Weber, Reinhold Kreutz, Otto A. Smiseth, Kristian Wachtell, Faiez Zannad, Sverre E. Kjeldsen, Enrico Agabiti Rosei, Athanasios J. Manolis, Konstantinos Tsioufis, João Pedro Ferreira, Miguel Camafort, Thomas G. von Lueder, Georg Ehret, Alexandros Kasiakogias, Andrzej Januszewicz, Thomas Kahan, Jana Brguljan, Luca Faconti
Hypertension constitutes a major risk factor for heart failure with preserved ejection fraction (HFpEF). HFpEF is a prevalent clinical syndrome with increased cardiovascular morbidity and mortality. Specific guideline-directed medical therapy (GDMT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a1c2bd18e7752775c603525b4c2795
http://hdl.handle.net/10852/92304
http://hdl.handle.net/10852/92304
Publikováno v:
Healthcare, Vol 8, Iss 406, p 406 (2020)
Healthcare
Healthcare
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition associated with several negative health outcomes. A hallmark of ME/CFS is decreased exercise capacity and often profound exercise intolerance. The cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df48b26b6999788d037a74d77676cfbd
http://hdl.handle.net/10852/80665
http://hdl.handle.net/10852/80665
Autor:
Ingrid Hopper, Ken Lee Chin, Richard Ofori-Asenso, Bing Hui Wang, Christopher M. Reid, Thomas G. von Lueder, Danny Liew, Sophia Zoungas
Publikováno v:
Cardiovascular Research. 115:266-276
There is growing evidence from Phase III randomized clinical trials of the cardiovascular benefits of sodium glucose cotransporter 2 (SGLT2) inhibitors in patients with diabetes mellitus. It is hypothesized that these benefits are mediated by mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad9cf8e341f3b94061bc01adcd1c658
https://doi.org/10.1093/cvr/cvy295
https://doi.org/10.1093/cvr/cvy295
Autor:
Giuseppe M.C. Rosano, John Kjekshus, Karina V Bunting, Andrew J.S. Coats, Alan S. Rigby, John J.V. McMurray, John Wikstrand, John G.F. Cleland, Bert Andersson, Douglas G. Altman, Dipak Kotecha, Michael Böhm, Frank Ruschitzka, Hans Wedel, Marcus Flather, Dirk J. van Veldhuisen, Luis Manzano, Thomas G. von Lueder, Jane Holmes, Milton Packer, Åke Hjalmarson
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
European Heart Journal, 39(1), 26-35. Oxford University Press
Consejería de Sanidad de la Comunidad de Madrid
European Heart Journal, 39(1), 26-35. Oxford University Press
Aims Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the effect of beta-blockers according to LVEF in double-blind, randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0e9c47973be816c30262e533f467ca
https://doi.org/10.1093/eurheartj/ehx564
https://doi.org/10.1093/eurheartj/ehx564
Autor:
Anders Opdahl, Thien Trung Tran, Ahmed K. Al-Ani, Pavel Hoffmann, Øyvind W. Skoe, Thomas G. von Lueder
Publikováno v:
EJVES Short Reports
EJVES Short Reports, Vol 42, Iss, Pp 34-36 (2019)
EJVES Short Reports, Vol 42, Iss, Pp 34-36 (2019)
Introduction Access site vascular complications in transfemoral transcatheter aortic valve implantation (TF-TAVI) are still a major concern. Recently, a novel collagen plug based closure device (Manta) was introduced. The results from the first repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a377a896c3e275284c9977da5c2fb11e
http://europepmc.org/articles/PMC6424680
http://europepmc.org/articles/PMC6424680
Autor:
Jane Holmes, Milton Packer, Marcus Flather, Thomas G. von Lueder, Giuseppe M.C. Rosano, John Wikstrand, Kevin Damman, John J.V. McMurray, Frank Ruschitzka, John G.F. Cleland, Michael Böhm, Dipak Kotecha, Simrat Gill, Hans Wedel, Andrew J.S. Coats, John Kjekshus, Josep Redon, Bert Andersson, Stefan D. Anker, Dirk J. van Veldhuisen, Alan S. Rigby, Luis Manzano
Publikováno v:
Journal of the American College of Cardiology, 74(23), 2893-2904. ELSEVIER SCIENCE INC
Background:\ud Moderate and moderately severe renal impairment are common in patients with heart failure and reduced ejection fraction, but whether beta-blockers are effective is unclear, leading to underuse of life-saving therapy.\ud \ud Objectives:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3f436771b33f388b9eade5f6445a091
https://pubmed.ncbi.nlm.nih.gov/32311722
https://pubmed.ncbi.nlm.nih.gov/32311722